| Neuraxpharm Switzerland AG - Tranxilium 5, Hartkapseln | | 33866 | | 01 | | Tranxilium 5 | | Hartkapseln | | N05BA05 | | Potassium Clorazepate | | 14.06.1971 | | |
| | Composition | | dikalii clorazepas 5 mg, kalii carbonas, talcum, Kapselhülle: gelatina, E 127, E 171, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Dipotassic Clorazepate | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Dipotassic Clorazepate | 5 mg |
| | | | Inactive agents | | additional_information |
|---|
| | | color. | | | | color. | | Gelatina | | Kapselhülle | | Potassium Carbonate | | | | | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 071 | 20 Capsule(s) | 1.86 | 11.25 | B | SL | No | | 072 | 50 Capsule(s) | 3.33 | 12.85 | B | SL | No |
|
|
